Colorectal cancer (CRC) screening is a major victory for gastroenterology. But the job is only half done, according to Michael B. Wallace, MD, MPH, who will explore the latest data on techniques to improve adenoma detection rate and better visualize difficult polyps during Sunday’s DDW Combined Clinical Symposium ‘Colorectal Cancer Screening.’ The symposium is jointly sponsored by AGA, ASGE and SSAT.
Some of the most important novel endoscopic research from around the world will be discussed Monday afternoon during the ASGE Presidential Plenary session, which will feature 10 innovative abstract presentations and four distinguished lectures. ASGE President Douglas O. Faigel, MD, FASGE, will moderate the 90-minute session and also deliver his presidential address, titled “Professionalism and the Professional Endoscopist: Words Matter.”
Sunday’s SSAT state-of-the-art conference ‘New Frontiers in Liver Surgery’ will highlight the latest research advances and surgical techniques, and examine how these advances are being shared with practitioners in developing countries to improve liver surgery outcomes worldwide, according to session co-moderator Amanda K. Arrington, MD. The 90-minute session is sponsored by the SSAT Research Committee.
Yngve Falck-Ytter, MD, was one of three experts who discussed the new Merit-Based Incentive Payment System (MIPS) during an AGA committee sponsored symposium Saturday afternoon. The Centers for Medicare and Medicaid Services created quality measures under the MIPS framework created by MACRA, the Medicare Access and CHIP Reauthorization Act of 2015.
Despite treatment success rates of 95 percent and better, hepatitis C (HCV) therapy can still improve. Finding a universal cure is the goal, according to Michael Fried, MD, who will moderate the AASLD Clinical Symposium ‘Prospects for New HCV Treatments’ Monday afternoon.
Carla W. Brady, MD, MHS – Assistant professor of medicine at Duke University Medical Center, Durham, NC.
During SSAT’s first Controversies in GI Surgery session Monday, experts will debate treatment options for achalasia as it’s defined under a new classification system.
Be sure to visit the ASGE Learning Center and ASGE Store at Digestive Disease Week® (DDW) to explore a wide variety of physician and patient education resources and products.
Basic science discoveries in the last three decades have made fibrosis one of the most dynamic frontiers in liver disease, according to Scott L. Friedman, MD, dean for therapeutic discovery and chief of the division of liver diseases at the Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
There are multiple types of cancer that develop in the gastrointestinal tract. Anil Rustgi, MD, is investigating how these GI cancers progress from normal tissue to metaplasia to dysplasia and then to cancer.